Antoine Wellink MSc 
Director Drug Development
Antoine Wellink received his degree in Chemical Engineering in 1992 from the University of Groningen, and trained in Economy and Marketing (University of Groningen), in Pharmacy (University of Utrecht) and Regulatory Affairs (ERA/BIRA).
He has vast experience in international business development and preclinical drug development with Merck KGaA and TNO Pharma and as Head of the Regulatory Affairs Department (20 employees) of WIL Research (NOTOX), a CRO dedicated to preclinical drug development.
Within Oncodrone, Antoine is responsible for drug development, regulatory affairs and protection and utilization of intellectual property.